NewsNovavax eyes bringing its COVID-19 vaccine to the U.S. marketAmerican biotechnology company Novavax says its COVID-19 vaccine has shown to have 90.4% effectiveness in a phase III clinical trial.
NewsWill COVID-19 vaccines work? What’s the timeline? Here’s the latest on vaccine progressDozens of companies worldwide are swiftly developing COVID-19 vaccines, with trillions of dollars and the health of the planet at stake. Here’s what you need to know.
Work LifeThere’s no such thing as self-sabotage. A psychotherapist debunks the most common concepts that keep us stuck